I agree that this site is using cookies. You can find further informations here.
X
Melamed, Lisa
44  results:
Search for persons X
?
1

DNAR-01. PAR-MEDIATED DNA DAMAGE SIGNALING IN IDH MUTANT GL..:

Kitagawa, Yosuke ; Nasser, Ali ; Chang, Chia...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v98-v98 , 2023
Link: https://doi.org/10.1093/..
 
?
2

DNAR-03. TARGETING POLY (ADP-RIBOSE) SIGNALING TO INDUCE LE..:

Kitagawa, Yosuke ; Wakimoto, Hiroaki ; Melamed, Lisa...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii90-vii91 , 2022
Link: https://doi.org/10.1093/..
 
?
3

EXTH-39. BIOMARKER DRIVEN TARGETING OF RECURRENT IDH MUTANT..:

Nasser, Ali ; Melamed, Lisa ; Nagashima, Hiroaki...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii218-vii218 , 2022
Link: https://doi.org/10.1093/..
 
?
4

EXTH-55. TARGETING RECURRENT IDH MUTANT GLIOMA WITH CDK4/6 ..:

Miller, Julie ; Cahill, Daniel ; Melamed, Lisa.
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi175-vi175 , 2021
Link: https://doi.org/10.1093/..
 
?
5

TAMI-20. POLY(ADP-RIBOSE) GLYCOHYDROLASE INHIBITION SEQUEST..:

Nagashima, Hiroaki ; Lee, Christine ; Tateishi, Kensuke...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii217-ii217 , 2020
Link: https://doi.org/10.1093/..
 
?
6

TAMI-36. CONNEXIN 43 BLOCKADE INHIBITS PROLIFERATION IN IDH..:

Melamed, Lisa ; Lee, Christine ; Nagashima, Hiroaki...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii220-ii221 , 2020
Link: https://doi.org/10.1093/..
 
?
7

Sirtuin activation targets IDH-mutant tumors:

Miller, Julie J ; Fink, Alexandria ; Banagis, Jack A...
Neuro-Oncology.  23 (2020)  1 - p. 53-62 , 2020
Link: https://doi.org/10.1093/..
 
?
8

The False Messiah of Tax Policy: What Elimination of the Ho..:

Follain, James R. ; Melamed, Lisa Sturman
Journal of Housing Research.  9 (1998)  2 - p. 179-199 , 1998
Link: https://www.jstor.org/st..
 
?
9

Emerging concepts in alcohol, infection & immunity: A summa..:

Rutt, Lauren N. ; Liu, Mengfei ; Melamed, Esther...
Alcohol.  118 (2024)  - p. 9-16 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Prognostic factors and outcomes in COVID-19 patients requir..:

Melamed, Roman ; Paz, Francisco ; Jepsen, Stacy...
Therapeutic Advances in Respiratory Disease.  16 (2022)  - p. 175346662210864 , 2022
Link: https://doi.org/10.1177/..
 
?
11

Utilization of point-of-care ultrasound and rotational thro..:

Phillips, Angela N. ; Kirkland, Lisa L. ; Wagner, William E...
Case Reports in Perinatal Medicine.  11 (2022)  1 - p. , 2022
Link: https://doi.org/10.1515/..
 
?
12

Local Adverse Reaction Rates Decreased over Time during Tre..:

Stein, Mark R. ; Wasserman, Richard L. ; Melamed, Isaac...
Journal of Allergy and Clinical Immunology.  137 (2016)  2 - p. AB220 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Long-Term Tolerability, Safety, and Efficacy of Recombinant..:

Wasserman, Richard L. ; Melamed, Isaac ; Stein, Mark R....
Journal of Clinical Immunology.  36 (2016)  6 - p. 571-582 , 2016
Link: https://doi.org/10.1007/..
 
?
14

Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid..:

Wasserman, Richard L. ; Lumry, William ; Harris III, James...
Journal of Clinical Immunology.  36 (2016)  6 - p. 590-599 , 2016
Link: https://doi.org/10.1007/..
 
?
15

Recombinant Human Hyaluronidase Facilitated Subcutaneous Im..:

Wasserman, Richard L ; Melamed, Isaac ; Kobrynski, Lisa...
Immunotherapy.  8 (2016)  10 - p. 1175-1186 , 2016
Link: https://doi.org/10.2217/..
 
1-15